This article addresses the Centers for Disease Control and Prevention recommendations for 2010–2011 seasonal influenza vaccination campaigns, identifies lessons learned, outlines new recommendations for preventing and controlling influenza this year, and encourages implementing flu vaccine clinics in the workplace.
References
1.
Centers for Disease Control and Prevention. (2000). Summary of the joint statement on thimerosal in vaccines: American Academy of Family Physicians, American Academy of Pediatrics, Advisory Committee on Immunization Practices, Public Health Service. Morbidity and Mortality Weekly Report, 49, 622, 631.
Centers for Disease Control and Prevention. (2010b). Seasonal influenza (flu). Retrieved from www.cdc.gov/flu
4.
Centers for Disease Control and Prevention. (2010c). Update: Influenza activity—United States, August 30, 2009-January 9, 2010. Morbidity and Mortality Weekly Report, 59(02), 38–43.
5.
FioreA. E.ShayD. K.BroderK.IskanderJ. K.UyekiT. M.MootreyG. (2009). Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. Morbidity and Mortality Weekly Report, 58(RR08), 1–52.
6.
FioreA. E.UyekiT. M.BroderK.FinelliL.EulerG. L.SingletonJ. A. (2010, August 6). Prevention and control of influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. Morbidity and Mortality Weekly Report, 59(RR08), 1–62.
7.
MeltzerM. I.NeuzilK. M.GriffinM. R.FukudaK. (2005). An economic analysis of annual influenza vaccination of children. Vaccine, 23, 1004–1014.
8.
MolinariN. A.Ortega-SanchezI. R.MessonnierM. L.ThompsonW. W.WortleyP. M.WeintraubE. (2007). The annual impact of seasonal influenza in the US: Measuring disease burden and costs. Vaccine, 25, 5086–5096.
9.
NicholK. L. (2001). Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Archives of Internal Medicine, 161, 749–759.
10.
NicholK. L.MallonK. P.MendelmanP. M. (2003). Cost benefit of influenza vaccination in healthy, working adults: An economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine. Vaccine, 21, 2207–2217.
11.
SanderB.KwongJ. C.BauchC. T.MaetzelA.McGeerA.RaboudJ. M. (2010). Economic appraisal of Ontario's universal influenza immunization program: A cost-utility analysis. PLoS Medicine, 7, e1000256.
